120 related articles for article (PubMed ID: 11875671)
1. Toxicity of chloroacetaldehyde is similar in adult and pediatric kidney tubules.
Dubourg L; Tanière P; Cochat P; Baverel G; Michoudet C
Pediatr Nephrol; 2002 Feb; 17(2):97-103. PubMed ID: 11875671
[TBL] [Abstract][Full Text] [Related]
2. Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide.
Dubourg L; Michoudet C; Cochat P; Baverel G
J Am Soc Nephrol; 2001 Aug; 12(8):1615-1623. PubMed ID: 11461933
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
Knouzy B; Dubourg L; Baverel G; Michoudet C
J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
[TBL] [Abstract][Full Text] [Related]
4. Targets of chloroacetaldehyde-induced nephrotoxicity.
Knouzy B; Dubourg L; Baverel G; Michoudet C
Toxicol In Vitro; 2010 Feb; 24(1):99-107. PubMed ID: 19733226
[TBL] [Abstract][Full Text] [Related]
5. Chloroacetaldehyde as a sulfhydryl reagent: the role of critical thiol groups in ifosfamide nephropathy.
Benesic A; Schwerdt G; Freudinger R; Mildenberger S; Groezinger F; Wollny B; Kirchhoff A; Gekle M
Kidney Blood Press Res; 2006; 29(5):280-93. PubMed ID: 17035713
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide.
Brüggemann SK; Kisro J; Wagner T
Cancer Res; 1997 Jul; 57(13):2676-80. PubMed ID: 9205076
[TBL] [Abstract][Full Text] [Related]
7. In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro.
Yaseen Z; Michoudet C; Baverel G; Dubourg L
Pediatr Nephrol; 2008 Apr; 23(4):611-8. PubMed ID: 18204866
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule.
Yaseen Z; Michoudet C; Baverel G; Dubourg L
Arch Toxicol; 2008 Sep; 82(9):607-14. PubMed ID: 18214444
[TBL] [Abstract][Full Text] [Related]
9. Investigation of ifosfamide and chloroacetaldehyde renal toxicity through integration of in vitro liver-kidney microfluidic data and pharmacokinetic-system biology models.
Leclerc E; Hamon J; Bois FY
J Appl Toxicol; 2016 Feb; 36(2):330-9. PubMed ID: 26152902
[TBL] [Abstract][Full Text] [Related]
10. Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity.
MacAllister SL; Martin-Brisac N; Lau V; Yang K; O'Brien PJ
Chem Biol Interact; 2013 Feb; 202(1-3):259-66. PubMed ID: 23220588
[TBL] [Abstract][Full Text] [Related]
11. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.
Zaki EL; Springate JE; Taub M
Toxicol In Vitro; 2003 Aug; 17(4):397-402. PubMed ID: 12849722
[TBL] [Abstract][Full Text] [Related]
12. Chloroacetaldehyde-induced hepatocyte cytotoxicity. Mechanisms for cytoprotection.
Sood C; O'Brien PJ
Biochem Pharmacol; 1994 Aug; 48(5):1025-32. PubMed ID: 8093090
[TBL] [Abstract][Full Text] [Related]
13. Mesna or cysteine prevents chloroacetaldehyde-induced cell death of human proximal tubule cells.
Schwerdt G; Kirchhoff A; Freudinger R; Wollny B; Benesic A; Gekle M
Pediatr Nephrol; 2007 Jun; 22(6):798-803. PubMed ID: 17273862
[TBL] [Abstract][Full Text] [Related]
14. Disturbed Ca2+-signaling by chloroacetaldehyde: a possible cause for chronic ifosfamide nephrotoxicity.
Benesic A; Schwerdt G; Mildenberger S; Freudinger R; Gordjani N; Gekle M
Kidney Int; 2005 Nov; 68(5):2029-41. PubMed ID: 16221203
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro.
Mills KA; Chess-Williams R; McDermott C
Arch Toxicol; 2019 Nov; 93(11):3291-3303. PubMed ID: 31598736
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
Springate J; Chan K; Lu H; Davies S; Taub M
In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of chloroacetaldehyde-induced cytotoxicity in isolated rat hepatocytes.
Sood C; O'Brien PJ
Biochem Pharmacol; 1993 Nov; 46(9):1621-6. PubMed ID: 8240419
[TBL] [Abstract][Full Text] [Related]
18. Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells.
Schwerdt G; Gordjani N; Benesic A; Freudinger R; Wollny B; Kirchhoff A; Gekle M
Pediatr Nephrol; 2006 Jan; 21(1):60-7. PubMed ID: 16267686
[TBL] [Abstract][Full Text] [Related]
19. Renal-tubule metabolism of ifosfamide to the nephrotoxic chloroacetaldehyde: pharmacokinetic modeling for estimation of intracellular levels.
Aleksa K; Ito S; Koren G
J Lab Clin Med; 2004 Mar; 143(3):159-62. PubMed ID: 15007305
[TBL] [Abstract][Full Text] [Related]
20. Necrotic pathway in human osteosarcoma Saos-2 cell death induced by chloroacetaldehyde.
Takahashi K; Sakurai K; Takahashi K; Tanaka H; Fujimoto Y
Anticancer Drugs; 2007 Jun; 18(5):543-53. PubMed ID: 17414623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
